Crater, G. D., Johnson, K., Ward, J., & Backer, J. D. (2022). Lung deposition of inhaled once-daily long-acting muscarinic antagonists standard jet nebulizer or dry powder inhaler, measured using functional respiratory imaging, in patients with chronic obstructive pulmonary disease. SAGE Publishing.
Chicago Style (17th ed.) CitationCrater, Glenn D., Karmon Johnson, Jonathan Ward, and Jan De Backer. Lung Deposition of Inhaled Once-daily Long-acting Muscarinic Antagonists Standard Jet Nebulizer or Dry Powder Inhaler, Measured Using Functional Respiratory Imaging, in Patients with Chronic Obstructive Pulmonary Disease. SAGE Publishing, 2022.
MLA (9th ed.) CitationCrater, Glenn D., et al. Lung Deposition of Inhaled Once-daily Long-acting Muscarinic Antagonists Standard Jet Nebulizer or Dry Powder Inhaler, Measured Using Functional Respiratory Imaging, in Patients with Chronic Obstructive Pulmonary Disease. SAGE Publishing, 2022.